The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure

This publication has 18 references indexed in Scilit:

• Correlation of exposure time, concentration and incorporation of IdUrd in V-79 cells with radiation response
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver
  Clinical Pharmacology & Therapeutics, 1988
• Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas
  Journal of Neurosurgery, 1988
• Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.
  Journal of Clinical Oncology, 1988
• Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumour sampling variations
  Radiotherapy and Oncology, 1988
• Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Analysis of bromodeoxyuridine incorporation into DNA: Comparison of gas chromatographic/mass spectrometric, CsCl gradient sedimentation, and specific radioactivity methods
  Analytical Biochemistry, 1987
• Modulation of 5-IODO-2′-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines
  Biochemical Pharmacology, 1985
• Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR)
  International Journal of Radiation Oncology*Biology*Physics, 1983
• GENETICS OF HUMAN CELL LINES
  The Journal of Experimental Medicine, 1960